Treatment and outcome of intracranial ependymoma after first relapse in AIEOP 2 nd protocol.
Maura MassiminoFrancesco BarrettaPiergiorgio ModenaPascal JohannPaolo FerroliManila AntonelliLorenza GandolaMaria Luisa GarrèDaniele BertinAngela MastronuzziMaurizio MascarinLucia QuagliettaElisabetta ViscardiIacopo SardiAntonio RuggieroLuna BoschettiMarzia GiagnacovoVeronica BiassoniElisabetta SchiavelloLuisa ChiappariniAlessandra ErbettaAnna MussanoCarlo GiussaniRosa Maria MuraSalvina BarraGiovanni ScarzelloGiuseppe ScimoneAndrea CaraiFelice GiangasperoFrancesca Romana ButtarelliPublished in: Neuro-oncology (2021)
Survival after recurrence was significantly influenced by symptoms and completeness of surgery. Only a homogeneous protocol with well posed, randomized questions could clarify the numerous issues, orient salvage treatment and ameliorate prognosis for this group of patients.
Keyphrases
- end stage renal disease
- randomized controlled trial
- newly diagnosed
- clinical trial
- chronic kidney disease
- open label
- double blind
- prognostic factors
- peritoneal dialysis
- free survival
- coronary artery bypass
- combination therapy
- percutaneous coronary intervention
- patient reported
- phase iii
- patient reported outcomes
- phase ii
- atrial fibrillation
- optic nerve